1978 W Winton Ave
Be part of pandemic-speed manufacturing for medicines
Talent is, and will always be, at the heart of our business. As part of our long-term growth strategy, we plan for significant expansion in Hayward, CA over the next 3 years. We are looking for talent to join us in various positions such as Quality Assurance, Operations, Regulatory, Engineering, Program Management, and many more.
We are one of the world's leading and most trusted suppliers to the pharmaceutical and biotech markets. We continue to break new ground within our industry, attracting global clients to our Hayward site. Rooted in the Bay Area and close to innovation in vaccines and therapeutics, we provide state-of-the-art, single-use manufacturing technology to support our customers with their clinical programs and through to commercial launch. Whether our customers are developing life-saving therapies for cancer or potential treatments for COVID-19, we can support them with world class manufacturing and process excellence.
With a history that dates back to 1897, Lonza is a trusted name with a wealth of knowledge and expertise in life science. Today we are more than 15,000 employees in more than 100 locations around the world. Together in 2019, we supported the development and production of over 1000 therapies.
We offer you exposure to upcoming biotech and established pharmaceutical companies and to the manufacturing technology needed to produce the potential blockbuster treatments of tomorrow. While other companies may only offer you the opportunity to work on a few treatments, at Lonza you will be working on scores of treatments per year for a variety of customers.
We are here to make a meaningful difference. It is the foundation of the way we do business. Looking after our people, our customers, our planet is core to our purpose. A career at Lonza is more than a job. We do not just work in the life sciences industries, we are transforming it. What we do today is helping to create a healthier, happier world tomorrow. That’s the meaningful difference we make every day.
211 articles with Lonza
Lonza Group Ltd. Announces the Extension of the Existing Supply Agreement with Bristol-Myers Squibb Company to Produce Until End 2013 ORENCIA®.
Martek Biosciences Corporation Wins Jury Verdict In Patent Infringement Case Against Lonza Group Ltd.; Key Martek Food And Production Patents Upheld Pending Final Action By Court
AplaGen GmbH And Lonza Ltd. Have Signed A Licensing Agreement For AplaGen's CFPS-Technology (Correctly Folded Peptide Synthesis)